Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy.
Xu YP, Lv L, Liu Y, Smith MD, Li WC, Tan XM, Cheng M, Li Z, Bovino M, Aubé J, Xiong Y.
Xu YP, et al. Among authors: smith md.
J Clin Invest. 2019 Jul 16;129(10):4316-4331. doi: 10.1172/JCI129317.
J Clin Invest. 2019.
PMID: 31310587
Free PMC article.